Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs ALHC✓SelectedUSD · ALHCMRNA vs ALHC performance historyLatest closeAs of-3.45%11/13
Stock and ETF performance explorer

MRNA vs ALHC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+218.1%
ALHC return
+22.7%
Excess return
+195.5%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioALHCExcessAlpha
1D-3.4%-1.9%-1.6%-3.4%
7D-12.1%+0.3%-12.4%-12.1%
30D-1.3%-10.6%+9.3%-1.3%
3M+250.9%-45.3%+296.3%+253.3%
6M+343.0%-59.7%+402.7%+355.9%
YTD+657.4%-62.7%+720.2%+680.2%
1Y+794.9%-56.1%+851.0%+824.8%
3Y+218.1%+21.3%+196.9%+204.3%
All+218.1%+22.7%+195.5%+204.3%

Cumulative growth

Daily Returns

Daily percentage return beside ALHC.

Daily Out/Under-Performance

Portfolio return minus ALHC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling